INHALE GDM – Gestational Diabetes

Trial Design: Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women with Gestational Diabetes
Inclusion Criteria:
Age ≥18 years and <50 years old
Singleton pregnancy at 24-34 weeks gestation
Treated with an insulin regimen
NCT Number: NCT06535789
Principal Investigator: Kristin Castorino
Status: Recruiting